Invesaro

Stocks Comparison

Progyny vs Sotera Health: revenue, profit, margins and growth compared

Progyny brought in $1.3B of revenue in fiscal 2025, Sotera Health $1.2B in fiscal 2025. Revenue changed by +10.4% at Progyny and +5.7% at Sotera Health on the year before, so Progyny grew faster. Progyny kept 4.5% of its revenue as net profit, Sotera Health 6.7%. Free cash flow was $191.8M at Progyny and $149.2M at Sotera Health.

Side by side, latest fiscal year

PGNYSHC
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$1.3B$1.2B
Revenue growth+10.4%+5.7%
Net income$58.5M$77.9M
Net margin4.5%6.7%
Free cash flow$191.8M$149.2M
Free cash flow margin14.9%12.8%
Earnings per share (diluted)$0.65$0.27
Cash$112.2M$344.6M
Debtn/a$2.1B
Price to earnings39.167.9
Market value$2B$5.2B
Dividend yieldn/an/a
Rank by revenue in sector#133 of 523 · Health care#138 of 523 · Health care

Over the years

Revenue
PGNY FY2019: $105.4MPGNY FY2019: $229.7MPGNY FY2020: $344.9MPGNY FY2021: $500.6MPGNY FY2022: $786.9MPGNY FY2023: $1.1BPGNY FY2024: $1.2BPGNY FY2025: $1.3BSHC FY2019: $778.3MSHC FY2021: $818.2MSHC FY2021: $931.5MSHC FY2022: $1BSHC FY2023: $1BSHC FY2024: $1.1BSHC FY2025: $1.2BFY19FY20FY21FY22FY23FY24FY25
PGNY $1.3BSHC $1.2B
Net income
PGNY FY2019: $661KPGNY FY2019: -$8.6MPGNY FY2020: $46.5MPGNY FY2021: $65.8MPGNY FY2022: $30.4MPGNY FY2023: $62MPGNY FY2024: $54.3MPGNY FY2025: $58.5MSHC FY2019: -$20.9MSHC FY2021: -$38.6MSHC FY2021: $116.9MSHC FY2022: -$233.6MSHC FY2023: $51.4MSHC FY2024: $44.4MSHC FY2025: $77.9MFY19FY20FY21FY22FY23FY24FY25
PGNY $58.5MSHC $77.9M
Net margin
PGNY FY2019: 0.6%PGNY FY2019: -3.7%PGNY FY2020: 13.5%PGNY FY2021: 13.1%PGNY FY2022: 3.9%PGNY FY2023: 5.7%PGNY FY2024: 4.7%PGNY FY2025: 4.5%SHC FY2019: -2.7%SHC FY2021: -4.7%SHC FY2021: 12.5%SHC FY2022: -23.3%SHC FY2023: 4.9%SHC FY2024: 4.0%SHC FY2025: 6.7%FY19FY20FY21FY22FY23FY24FY25
PGNY 4.5%SHC 6.7%
Revenue growth
PGNY FY2019: +117.9%PGNY FY2020: +50.1%PGNY FY2021: +45.2%PGNY FY2022: +57.2%PGNY FY2023: +38.3%PGNY FY2024: +7.2%PGNY FY2025: +10.4%SHC FY2021: +5.1%SHC FY2021: +13.9%SHC FY2022: +7.8%SHC FY2023: +4.5%SHC FY2024: +4.9%SHC FY2025: +5.7%FY19FY20FY21FY22FY23FY24FY25
PGNY +10.4%SHC +5.7%
Free cash flow
PGNY FY2019: $1.7MPGNY FY2019: -$4.5MPGNY FY2020: $35.2MPGNY FY2021: $23.9MPGNY FY2022: $77.2MPGNY FY2023: $185.2MPGNY FY2024: $173.7MPGNY FY2025: $191.8MSHC FY2019: $91.8MSHC FY2021: $67.1MSHC FY2021: $179.4MSHC FY2022: $95.6MSHC FY2023: -$362.7MSHC FY2024: $45.1MSHC FY2025: $149.2MFY19FY20FY21FY22FY23FY24FY25
PGNY $191.8MSHC $149.2M

Fiscal years as each company reports them; the two may end in different months.

Questions about Progyny and Sotera Health

Which is bigger by revenue, Progyny or Sotera Health?

Progyny is bigger by revenue: $1.3B in fiscal 2025, against $1.2B for Sotera Health in fiscal 2025.

Which keeps more of its revenue as profit, Progyny or Sotera Health?

Progyny had a net margin of 4.5% in fiscal 2025; Sotera Health had 6.7% in fiscal 2025.

Which grew revenue faster, Progyny or Sotera Health?

In their latest fiscal years revenue changed by +10.4% at Progyny and +5.7% at Sotera Health.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies